Evidence map›Paper›PMID 36561276›Full record

ReviewFrontiers in global women's health2022

Gender-based violence programming in times of COVID-19: Challenges, strategies and recommendations.

Mridu Markan, Radhika Dhingra, Mehak Segan, Vandana Dabla, Moni Sagar, Sharmila Neogi, Shrija Dey, Nayan Chakravarty

Abstract readReview
In one paragraph

Review in Frontiers in global women's health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mridu MarkanUSAID's Momentum Country and Global Leadership: India-Yash, Jhpiego, New Delhi, India.
Radhika DhingraUSAID's Momentum Country and Global Leadership: India-Yash, Jhpiego, New Delhi, India.
Mehak SeganUSAID's Momentum Country and Global Leadership: India-Yash, Jhpiego, New Delhi, India.
Vandana DablaUSAID's Momentum Country and Global Leadership: India-Yash, Jhpiego, New Delhi, India.
Moni SagarUSAID, New Delhi, India.
Sharmila NeogiUSAID, New Delhi, India.
Shrija DeyUSAID's Momentum Country and Global Leadership: India-Yash, Jhpiego, New Delhi, India.
Nayan ChakravartyUSAID's Momentum Country and Global Leadership: India-Yash, Jhpiego, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gender-Based Violence (GBV) remains the most challenging and threatening manifestation of gender inequality in Indian society. The outbreak of COVID-19 in India increased the risk of exposure to GBV, often compared to the "shadow pandemic". Girls suffered disproportionally compared to boys during the pandemic -from being pulled out of schools, facing movement restrictions, and being more susceptible to forced marriage and household violence. Pre-existing gender inequalities and regressive gender norms, along with economic instability, also contributed to creating a milieu for violence to thrive. Additionally, the pandemic also challenged GBV service provision and program implementation at the community level. To meet the increasing needs of women and girls during the crisis, national and local civil society organizations attempted to adapt GBV programming and promote innovative approaches to tackle GBV. The secondary review provides insight on the GBV impact due to the COVID-19 pandemic and provides an overview of various challenges at the level of individual, community, institution, and policy. The literature review also highlights strategies adopted to combat GBV in private, public and cyberspace.

Indexed as

COVID-19GBV challengesGBV IndiaGBV programminggender based violence

Identifiers

PMID36561276
PMCPMC9763468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.